COHEN CHARLES J. 4
4 · Xenon Pharmaceuticals Inc. · Filed Mar 13, 2018
Insider Transaction Report
Form 4
COHEN CHARLES J.
VP, Biology
Transactions
- Award
Stock Option (Right to Buy)
2018-03-12+40,000→ 40,000 totalExercise: $4.75Exp: 2028-03-11→ Common Shares (40,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2019, and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.